Jin Medical International Ltd. income statement

In fiscal 2025, Jin Medical International Ltd. reported revenue of $20.7m, down 12.0% on the year before, operating income of $608,182 (a 2.9% margin) and net income of $1.2m, or $0.01 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Jin Medical International Ltd.: income statement, annual
Fiscal year	2021Sept 2021	2022Sept 2022	2023Sept 2023	2024Sept 2024	2025Sept 2025
Revenue	21	19	20	24	21
Cost of revenue	14	13	13	14	15
Gross profit	6	6	7	10	6
Research and development	2	2	2	1	2
General and administrative	2	2	2	3	3
Operating income	3	2	3	4	1
Net interest income	−0	0	0	—	—
Income before tax	3	3	3	4	2
Income tax	0	0	0	1	0
Net income	3	3	3	4	1
Diluted EPS	$0.02	$0.02	$0.02	$0.02	$0.01
Diluted shares (average)	135m	135m	145m	156m	157m
EBITDA	3	2	3	4	1

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: NEPH vs ZJYL VVOS vs ZJYL SNOA vs ZJYL SRTS vs ZJYL

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Jin Medical International Ltd.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Jin Medical International Ltd.